Search Results

search
22157.jpg
Refractory Metastatic Melanoma Pipeline Report 2025, with Focus on BioNTech SE, Y-mAbs and Therapeutics Seagen
March 20, 2025 13:36 ET | Research and Markets
Dublin, March 20, 2025 (GLOBE NEWSWIRE) -- The "Refractory Metastatic Melanoma - Pipeline Insight, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The report provides...
Logo.png
Rich Insights Into The Robust Metastatic Melanoma Clinical Trials Pipeline Analysis Featuring 75+ Companies DelveInsight
August 18, 2022 13:00 ET | DelveInsight Business Research LLP
New York, USA, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Rich Insights Into The Robust Metastatic Melanoma Clinical Trials Pipeline Analysis Featuring 75+ Companies DelveInsight The prevalence of skin...